I'd love to see licensing as JDP has stated, however, I can't see it being appealing to pharma at the same time as financially beneficial to RAC.
One of the speculations I've thrown around to a few people is that RAC will organise a loan structure. If only there were someone with enough conviction, and deep enough pockets to loan a measly few mill to RAC....
Ann: Race Strategic Update August 2023, page-574
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.045(2.73%) |
Mkt cap ! $273.5M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.66 | $1.61 | $159.4K | 98.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5684 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |